Loss of glucocorticoid receptor expression in diagnostic biopsies of metastatic prostate cancer is associated with poor response to sequential docetaxel treatment

被引：0
|
作者：
Moll, J. M. [1 ]
Mout, L. [1 ]
Kweldam, C. F. [2 ]
Wissing, M. [3 ]
de Morree, E. M. [1 ]
Van Leenders, G. J. L. H. [2 ]
Jenster, G. W. [1 ]
Van Weerden, W. M. [1 ]
机构：
[1] Erasmus MC, Dept Urol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Pathol, Rotterdam, Netherlands
[3] LUMC, Dept Med Oncol, Leiden, Netherlands
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0533
引用
收藏
页码：S1423 / S1423
页数：1
相关论文
共 50 条
  • [1] IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer
    Maynard, Janielle P.
    Ertunc, Onur
    Kulac, Ibrahim
    Baena-Del Valle, Javier A.
    De Marzo, Angelo M.
    Sfanos, Karen S.
    MOLECULAR CANCER RESEARCH, 2020, 18 (01) : 153 - 165
  • [2] Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression
    Komura, Kazumasa
    Jeong, Seong Ho
    Hinohara, Kunihiko
    Qu, Fangfang
    Wang, Xiaodong
    Hiraki, Masayuki
    Azuma, Haruhito
    Lee, Gwo-Shu Mary
    Kantoff, Philip W.
    Sweeney, Christopher J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (22) : 6259 - 6264
  • [3] The predictive value of chromogranin a expression for docetaxel response in metastatic hormone refractory prostate cancer
    Gernone, A.
    Trabucco, S.
    Pagliarulo, V.
    Troccoli, G.
    Pagliarulo, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 100 - 100
  • [4] Re: Resistance to Docetaxel in Prostate Cancer is Associated with Androgen Receptor Activation and Loss of KDM5D Expression
    Atala, Anthony
    JOURNAL OF UROLOGY, 2017, 197 (01): : 154 - 155
  • [5] Prognostic role of chromogranin A expression for docetaxel response in hormone-refractory metastatic prostate cancer
    Gernone, A.
    Trabucco, S.
    Troccoli, G.
    Pagliarulo, V.
    Pagliarulo, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] The differential expression of BCL-2 and docetaxel response in metastatic hormone refractory prostate cancer
    Gemone, A.
    Trabucco, S.
    Troccoli, G.
    Pagliarulo, A.
    Pagliarulo, V
    ANNALS OF ONCOLOGY, 2006, 17 : XI83 - XI83
  • [7] Loss of Sef (similar expression to FGF) expression is associated with high grade and metastatic prostate cancer
    Darby, S.
    Sahadevan, K.
    Khan, M. M.
    Robson, C. N.
    Leung, H. Y.
    Gnanapragasam, V. J.
    ONCOGENE, 2006, 25 (29) : 4122 - 4127
  • [8] Loss of Sef (similar expression to FGF) expression is associated with high grade and metastatic prostate cancer
    S Darby
    K Sahadevan
    M M Khan
    C N Robson
    H Y Leung
    V J Gnanapragasam
    Oncogene, 2006, 25 : 4122 - 4127
  • [9] Prognostic role of chromogranin a expression for docetaxel response in metastatic hormone-refractory prostate cancer (HRPC)
    Gernone, Angela
    Trabucco, Senia
    Pagliarulo, Vincenzo
    Troccoli, Giuseppe
    Pagliarulo, Arcangelo
    ANNALS OF ONCOLOGY, 2007, 18 : 65 - 65
  • [10] Glucocorticoid Receptor Expression Is Increased in Primary Recurrent Prostate Cancer, Castration Resistant Localized and Metastatic Disease
    Tretiakova, Maria
    True, Lawrence
    Montgomery, Bruce
    Taplin, Mary-Ellen
    Nelson, Peter S.
    MODERN PATHOLOGY, 2017, 30 : 263A - 263A
12345